Volume 34 Number 4 January 29 - February 5, 2015
Antimicrobials, Vaccines, Interventions
Ultradeep pyrosequencing of NS3 to predict response to triple therapy with protease inhibitors in previously treated chronic hepatitis C patients
Larrat S, et al. J Clin Microbiol 2015; 53(2):389-397.
Larrat S, et al. J Clin Microbiol 2015; 53(2):389-397.
Viral genetic diversity and polymorphisms in a cohort of HIV-1 infected patients eligible for the initiation of antiretroviral therapy in Abuja, Nigeria.
Yang C, et al. AIDS Res Hum Retroviruses. 2015 Jan 12.
Yang C, et al. AIDS Res Hum Retroviruses. 2015 Jan 12.
Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial
Sarwar UN, et al. J Infect Dis 2015; 211 (4): 549-557.
Sarwar UN, et al. J Infect Dis 2015; 211 (4): 549-557.
Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment
Monath TP, et al. Vaccine. 2015 Jan 1;33(1):62-72.
Monath TP, et al. Vaccine. 2015 Jan 1;33(1):62-72.


No hay comentarios:
Publicar un comentario